Nectar Lifesciences Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Amit Chadah

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	4.1yrs
Participación del CEO	n/a
Permanencia media de la dirección	2yrs
Promedio de permanencia en la Junta Directiva	3.2yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Amit Chadah (54 yo)

4.1yrs

Permanencia

Mr. Amit Chadah serves as the Chief Executive Officer of Nectar Lifesciences Limited since October 30, 2020. He was President of Business Development until October 30, 2020. He has joined the Nectar Lifesc...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Sanjiv Goyal	Chairman & MD	no data	₹22.65m	44.35% ₹ 3.3b
Puneet Sud	Director of Operations & Wholetime Director	no data	₹6.46m	sin datos
Amit Chadah	Chief Executive Officer	4.1yrs	sin datos	sin datos
Sushil Kapoor	Chief Financial Officer	2yrs	sin datos	sin datos
Vikas Vij	Chief Operating Officer	no data	sin datos	sin datos
Neha Vaishnav	Company Secretary & Compliance Officer	1.9yrs	sin datos	sin datos

2.0yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 532649 se considera experimentado (2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Sanjiv Goyal	Chairman & MD	no data	₹22.65m	44.35% ₹ 3.3b
Puneet Sud	Director of Operations & Wholetime Director	2.2yrs	₹6.46m	sin datos
Meena Verma	Nominee Director	5.8yrs	₹80.00k	sin datos
Rupinder Tewari	Independent & Non-Executive Director	5.8yrs	₹75.00k	sin datos
Kuldip Bhasin	Independent & Non-Executive Director	3.2yrs	₹120.00k	sin datos
Indu Kaur	Independent & Non-Executive Director	2.3yrs	₹120.00k	sin datos

3.2yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 532649 se considera experimentada (3.2 años de antigüedad promedio).

Nectar Lifesciences Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Nectar Lifesciences Limited, Annual General Meeting, Sep 21, 2024

Nectar Lifesciences Limited, Annual General Meeting, Sep 21, 2023

Nectar Lifesciences Limited Appoints Neha Vaishnav as the Company Secretary

Nectar Lifesciences Limited Announces Executive Changes

Nectar Lifesciences Limited Appoints Puneet Sud as Additional Director on the Board

Nectar Lifesciences Limited Announces Resignation of Director, Sanjit Singh Lamba

Recent updates

Nectar Lifesciences Limited Provides Update on Details of Litigation Orders

Second quarter 2025 earnings released: EPS: ₹0.25 (vs ₹0.05 in 2Q 2024)

Nectar Lifesciences Limited to Report Q2, 2025 Results on Nov 14, 2024

Nectar Lifesciences Limited Provides Update on Details of Litigation Orders Passed Principal Commissioner of Income Tax (Central), Gurugram

New minor risk - Market cap size

Nectar Lifesciences Limited Provides Update on Details of Litigation And/ or Orders Passed by Any Regulatory Authority or Judicial Body

New minor risk - Share price stability

First quarter 2025 earnings released: EPS: ₹0.13 (vs ₹0.08 in 1Q 2024)

Nectar Lifesciences Limited, Annual General Meeting, Sep 21, 2024

Nectar Lifesciences Limited to Report Q1, 2025 Results on Aug 14, 2024

Nectar Lifesciences Limited to Report Fiscal Year 2024 Results on May 15, 2024

New minor risk - Share price stability

Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.41 loss in 3Q 2023)

Nectar Lifesciences Limited to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: EPS: ₹0.05 (vs ₹1.00 loss in 2Q 2023)

Nectar Lifesciences Limited to Report Q2, 2024 Results on Nov 10, 2023

New minor risk - Share price stability

Full year 2023 earnings released: ₹1.08 loss per share (vs ₹1.12 profit in FY 2022)

Nectar Lifesciences Limited to Report Q1, 2024 Results on Aug 14, 2023

New minor risk - Share price stability

Full year 2023 earnings released: ₹1.08 loss per share (vs ₹1.12 profit in FY 2022)

Nectar Lifesciences Limited, Annual General Meeting, Sep 21, 2023

Nectar Lifesciences Limited to Report Fiscal Year 2023 Results on May 26, 2023

Nectar Lifesciences Limited Appoints Neha Vaishnav as the Company Secretary

Third quarter 2023 earnings released: ₹0.41 loss per share (vs ₹0.43 profit in 3Q 2022)

Nectar Lifesciences Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: ₹1.00 loss per share (vs ₹0.08 profit in 2Q 2022)

Nectar Lifesciences Limited Announces Executive Changes

Nectar Lifesciences Limited to Report Q2, 2023 Results on Nov 14, 2022

Nectar Lifesciences Limited Appoints Puneet Sud as Additional Director on the Board

Nectar Lifesciences Limited Announces Resignation of Director, Sanjit Singh Lamba

First quarter 2023 earnings released: EPS: ₹0.17 (vs ₹0.08 in 1Q 2022)

Nectar Lifesciences Limited Appoints Indu Pal Kaur as an Independent (Woman) Director

Nectar Lifesciences Limited Announces Resignation of Dinesh Dua as an Executive Director as Well as Director, Effective July 09, 2022

Full year 2022 earnings released: EPS: ₹1.12 (vs ₹3.27 loss in FY 2021)

Nectar Lifesciences Limited, Annual General Meeting, Sep 21, 2022

Nectar Lifesciences Limited to Report Fiscal Year 2022 Results on May 30, 2022

Nectar Lifesciences Limited Announces Resignation of Guljit Sethi as Board Member, Effective May 09, 2022

Nectar Lifesciences Limited Announces Resignation of Vivek Sett as Director

Now 20% undervalued after recent price drop

Now 20% undervalued

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Nectar Lifesciences Limited to Report Q3, 2022 Results on Feb 14, 2022

Second quarter 2022 earnings released: EPS ₹0.08 (vs ₹0.33 loss in 2Q 2021)

Full year 2021 earnings released: ₹3.27 loss per share (vs ₹1.42 profit in FY 2020)

Additional Independent Director Ajit Dhillon has left the company

Company Secretary & Compliance Officer Sukriti Saini has left the company

Nectar Lifesciences Limited Appoints Ajit Singh Dhillon as Additional Director

Third quarter 2021 earnings released: ₹0.36 loss per share (vs ₹0.37 profit in 3Q 2020)

Nectar Lifesciences Limited to Report Q3, 2021 Results on Feb 13, 2021

New 90-day high: ₹23.95

Nectar Lifesciences Limited Announces Demise of Dr. (Maj Gen.) S.S. Chauhan, Independent Director

Second quarter 2021 earnings released: ₹0.33 loss per share

Nectar Lifesciences Limited Appoints Amit Chadah as Chief Executive Officer

New 90-day low: ₹19.80

First quarter earnings released

Nectar Lifesciences Limited to Report Q1, 2021 Results on Oct 01, 2020

Upcoming Dividend of ₹0.05 Per Share

Earnings released

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad